Dana Goldman, Ph.D.
Leonard D. Schaeffer Director's Chair, USC Sol Price School of Public Policy and School of Pharmacy, and Director, Leonard D. Schaeffer Center for Health Policy and Economics,
University of Southern California
Dana Goldman is a Professor and the Leonard D. Schaeffer Director’s Chair at the University of Southern California. Until Fall 2009, he held RAND’s Distinguished Chair in Health Economics and directed RAND’s program in Economics, Finance, and Organization. He is also an Adjunct Professor of Health Services and Radiology at UCLA. Dr. Goldman is a nationally-recognized health economist influential in both academic and policy circles. He is the author of over 100 articles and book chapters, including articles in some of the most prestigious medical, economic, health policy, and statistics journals. He is a health policy advisor to the Congressional Budget Office, and is a frequent speaker on health care issues. He serves on several editorial boards including Health Affairs and the American Journal of Managed Care. He is also a founding editor of the Forum for Health Economics and Policy, an online journal devoted to health economics and health policy. Dr. Goldman’s work has been featured in the New York Times, Wall Street Journal, Washington Post, Business Week, U.S. News and World Report, The Economist, NBC Nightly News, CNN, National Public Radio, and other media. Dr. Goldman was the 2009 recipient of the Eugene Garfield Economic Impact Prize, recognizing outstanding research demonstrating how medical research impacts the economy. He was awarded the National Institute for Health Care Management Research Foundation award for excellence in health policy, and the Alice S. Hersh New Investigator Award recognizing the contributions of a young scholar to the field of health services research. He also has served on several panels for the National Academy of Sciences and Institute of Medicine, including a current panel on the fiscal future of the United States. Dr. Goldman’s research sponsors include the National Institutes of Health, National Institute on Aging, National Cancer Institute, National Science Foundation, Amgen, Merck, Genentech, Pfizer, UnitedHealth, Pacificare, California Healthcare Foundation, Smith Richardson Foundation, Department of Defense, Department of Labor, and the Agency for Healthcare Research and Quality. Dr. Goldman is also a research associate with the National Bureau of Economic Research, the nation’s leading economic research organization. He is the director of the RAND/UCLA Health Services Research Postdoctoral Training Program. He is also a founder and managing director of Precision Health Economics, a consulting firm to the health care industry. Dr. Goldman received his B.A. summa cum laude from Cornell University and a Ph.D. in Economics from Stanford University.
Medical Innovation & Regulation, Pharmacoeconomics, Health Care Costs, Public Health, Comparative Effectiveness & Outcomes, Global Health Policy, Patient Centered Outcomes
- The benefits from giving makers of conventional ‘small molecule’ drugs longer exclusivity over clinical trial data
- Differences in health between Americans and Western Europeans: Effects on longevity and public finance